nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An appraisal of subcutaneous trastuzumab: a new formulation meeting clinical needs
|
Launay-Vacher, Vincent |
|
2013 |
72 |
6 |
p. 1361-1367 |
artikel |
2 |
Angiotensin-(1–7) synergizes with colony-stimulating factors in hematopoietic recovery
|
Rodgers, Kathleen E. |
|
2013 |
72 |
6 |
p. 1235-1245 |
artikel |
3 |
A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS-mediated c-Abl/p38 MAPK signaling
|
Chung, Kyung-Sook |
|
2013 |
72 |
6 |
p. 1315-1324 |
artikel |
4 |
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401
|
Oh, In-Jae |
|
2013 |
72 |
6 |
p. 1247-1254 |
artikel |
5 |
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
|
Horsley, Laura |
|
2013 |
72 |
6 |
p. 1343-1352 |
artikel |
6 |
A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer
|
Nakai, Yousuke |
|
2013 |
72 |
6 |
p. 1291-1297 |
artikel |
7 |
13C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients
|
Cunha-Junior, Geraldo Felício |
|
2013 |
72 |
6 |
p. 1273-1282 |
artikel |
8 |
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis
|
Bousquet, Guilhem |
|
2013 |
72 |
6 |
p. 1183-1193 |
artikel |
9 |
Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice
|
Parise, Robert A. |
|
2013 |
72 |
6 |
p. 1195-1204 |
artikel |
10 |
Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments
|
Pauley, Jennifer L. |
|
2013 |
72 |
6 |
p. 1375 |
artikel |
11 |
Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period
|
Kobayashi, Shogo |
|
2013 |
72 |
6 |
p. 1325-1333 |
artikel |
12 |
Flow cytometric chemosensitivity assay using JC-1, a sensor of mitochondrial transmembrane potential, in acute leukemia
|
Yokosuka, Tomoko |
|
2013 |
72 |
6 |
p. 1335-1342 |
artikel |
13 |
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
|
Kono, Toru |
|
2013 |
72 |
6 |
p. 1283-1290 |
artikel |
14 |
Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers
|
Dutreix, Catherine |
|
2013 |
72 |
6 |
p. 1223-1234 |
artikel |
15 |
Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients
|
Ahmed, Tamer A. |
|
2013 |
72 |
6 |
p. 1369-1374 |
artikel |
16 |
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
|
Molife, L. Rhoda |
|
2013 |
72 |
6 |
p. 1213-1222 |
artikel |
17 |
Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401
|
Takayama, Koichi |
|
2013 |
72 |
6 |
p. 1353-1359 |
artikel |
18 |
Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics
|
Motoshima, Kohei |
|
2013 |
72 |
6 |
p. 1299-1304 |
artikel |
19 |
Phase 1 study of N1,N11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma
|
Goyal, Lipika |
|
2013 |
72 |
6 |
p. 1305-1314 |
artikel |
20 |
Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase
|
Palani, Santhosh |
|
2013 |
72 |
6 |
p. 1255-1264 |
artikel |
21 |
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study
|
Jankowitz, Rachel C. |
|
2013 |
72 |
6 |
p. 1205-1212 |
artikel |
22 |
The role of antioxidants in the era of cardio-oncology
|
Vincent, Duncan T. |
|
2013 |
72 |
6 |
p. 1157-1168 |
artikel |
23 |
The VEGF pathway in lung cancer
|
Alevizakos, Michalis |
|
2013 |
72 |
6 |
p. 1169-1181 |
artikel |
24 |
Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastases
|
Garcia, Sean S. |
|
2013 |
72 |
6 |
p. 1265-1271 |
artikel |